High-intensity Interval Training Prescriptions to Reduce the Risk of Complications Linked to Type… (NCT04986345) | Clinical Trial Compass
UnknownNot Applicable
High-intensity Interval Training Prescriptions to Reduce the Risk of Complications Linked to Type 2 Diabetes: the Role of Interval Length on Clinical Benefits and on Physiological Mechanisms
Canada15 participantsStarted 2021-10-04
Plain-language summary
Type 2 diabetes (T2D) prevalence has steadily been rising in the past decades and its complications, including cardiovascular diseases (CVD), are a major public health concern.
To lower CVD risk and to maintain an adequate glycemic control, Diabetes Canada recommends aerobic exercise of high-intensity interval training (HIIT). The leading hypothesis of this study is that longer intervals will favor an anti-inflammatory immune state, and that and that it will be correlated with reduced arterial stiffness and blood pressure.
Who can participate
Age range
60 Years – 80 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* With a diagnostic for type 2 diabetes
* Arterial hypertension (controlled at rest)
* Low or no alcohol consumption (≤ 7 alcoholic beverages/week)
* Non-smoking
* Physically active ( \> 60 minutes of structured and scheduled physical activity/week for the previous 3 months)
Exclusion Criteria:
* Insulin therapy
* Use of beta blockers
* Unstable medication in the past 6 months
* Stroke in the past 6 months, or with consequences limiting physical activity practice
* Coronary disease without revascularization, or peripheral artery disease
* Neuropathy, retinopathy of nephropathy diagnostics
* Orthopedic limitations, or medical counter-indication for physical activity practice
* Surgery scheduled during the study period
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in ambulatory systolic and diastolic blood pressure
Timeframe: During 24 hours after the three experimental conditions (Rest, HIIT-4 and HIIT-10)